A detailed history of Quest Partners LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Quest Partners LLC holds 1,249 shares of UTHR stock, worth $454,198. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,249
Previous 279 347.67%
Holding current value
$454,198
Previous $88.9 Million 403.61%
% of portfolio
0.04%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$311.04 - $363.55 $301,708 - $352,643
970 Added 347.67%
1,249 $448 Million
Q2 2024

Aug 06, 2024

SELL
$228.26 - $319.04 $28,532 - $39,880
-125 Reduced 30.94%
279 $88.9 Million
Q1 2024

May 09, 2024

SELL
$210.76 - $249.51 $652,512 - $772,482
-3,096 Reduced 88.46%
404 $92.8 Million
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $752,080 - $899,290
3,500 New
3,500 $770 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.